WHO Pharmaceuticals Newsletter 1999, No. 05&06
(1999; 20 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentAngiotensin II receptor antagonists losartan and irbesartan: review of adverse reactions: Australia.
View the documentAsian remedy for menstrual cramps (“Koo Sar Pills”): lead poisoning in an adult reported: United States of America.
View the documentAzathioprine and allopurinol: interaction: Australia.
View the documentEchinacea: allergic reactions: Australia.
View the documentVigabatrin: visual field defects: update: Australia.
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsMedication errors
Open this folder and view contentsGeneral information
Open this folder and view contentsVeterinary medicine
 

Azathioprine and allopurinol: interaction: Australia.

Allopurinol interferes with degradation of azathioprine to cause a 3- to 4-fold increase in its cytotoxic capacity. This can result in severe and potentially fatal pancytopenia. A patient is reported who was receiving azathioprine and had self-administered allopurinol for an attack of gout. Multinucleated red cell precursors with grossly abnormal features relative to normal erythroblasts provided evidence of the resulting bone marrow toxicity.

Patients taking azathioprine must be alerted to the danger of co-medication with allopurinol.

Reference: Australian Prescriber 22 (1): 19, 1999.

to previous section to next section
 

Last updated: May 3, 2013